
Multipurpose Prevention Technology (MPT) Manufacturing Issues
In this live webinar, Dr. Joseph Romano (NWJ Group/IMPT), Kenneth Stockholm (Q Pharma), and Robert Russell (RJR Consulting) review CMO perspectives, cost of MPT product development and marketing, scalability, and more.
September 2014
Click for full info +Multipurpose Prevention Technology (MPT) Manufacturing Issues
![]() | 26 September 2014 In this live webinar, Dr. Joseph Romano (NWJ Group/IMPT), Kenneth Stockholm (Q Pharma), and Robert Russell (RJR Consulting) review CMO perspectives, cost of MPT product development and marketing, scalability, and more. • View Presentation Romano, J., Stockholm, K., & Russell, R. |
Full Info:
Resource Type:
Citation:
In this live webinar, Dr. Joseph Romano (NWJ Group/IMPT), Kenneth Stockholm (Q Pharma), and Robert Russell (RJR Consulting) review CMO perspectives, cost of MPT product development and marketing, scalability, and more.
Authors: Romano, J., Stockholm, K., & Russell, R.
Health Risks(s):
- HIV
- STI / STD
- Unintended Pregnancy
Product type(s):
- MPTs
Topic(s):
- Development
Additional Keywords:
HIV + STIs + unintended pregnancy MPTs Webinar